Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Anti-Cancer Drugs|March 7, 2024
Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancerGozde Kavgaci, Omer Dizdar, Suayib Yalcin
Cancers|August 12, 2023
Advances in the Early Detection of Hepatobiliary CancersHasan Çağrı Yıldırım, Gozde Kavgaci, Elvin Chalabiyev, et al.
Anti-Cancer Drugs|November 29, 2023
Acute heart failure following pazopanib treatment: a literature review featuring two case reportsNeyran Kertmen, Gozde Kavgaci, Hasan Cagri Yildirim, et al.
Cancer Treatment Reviews|May 14, 2025
Drug-Drug interactions and special considerations in breast cancer patients treated with CDK4/6 inhibitors: A comprehensive reviewTaha Koray Sahin, Gozde Kavgaci, Deniz Can Guven, et al.
Journal of Chemotherapy (Florence, Italy)|November 29, 2024
Ribociclib-induced autoimmune-like hepatitis: a case reportGozde Kavgaci, Taha Koray Sahin, Cenk Sokmensuer, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 15, 2025
Evaluating Immunotherapy Responses in Neuro-Oncology for Glioblastoma and Brain Metastases: A Brief Review Featuring Three CasesNeyran Kertmen, Gozde Kavgaci, Serkan Akin, et al.
Expert Review of Anticancer Therapy|December 14, 2024
Post-operative serum CEA predicts prognosis in HR-positive/HER2-negative early breast cancerGozde Kavgaci, Taha Koray Sahin, Tugcenur Muderrisoglu, et al.
Oncology Letters|January 29, 2025
Sequential immunotherapy and bevacizumab treatments in glioblastoma multiforme: A case series and review of the literatureNeyran Kertmen, Gozde Kavgaci, Ilgin Koc, et al.
Molecular Oncology|May 24, 2025
Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8-year study of 10 754 patients in TurkeyGozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, et al.
Molecular and Clinical Oncology|November 12, 2025
Prognostic significance of ductal carcinoma <i>in situ</i> coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomesNeslihan Koray Fedai, Ilgin Koc, Gozde Kavgaci, et al.
Pageof 2